Welcome to Bioculture Group, the pioneer in cynomolgus monkey breeding and export in Mauritius since 1985. Our mission is “Caring for life” by caring for animals which directly contribute to ground-breaking medical research leading to the development of medical treatments which benefit hundreds of millions of people around the world.
Read the latest animal research news involving Cynomolgus monkeys and their contribution in the development of ground-breaking treatments for illnesses and conditions ranging from diabetes and cardiovascular diseases to corona viruses.
Bioculture Group recognises the profound impact that Corporate Social Responsibility (CSR) initiatives can have on communities. With a strong commitment to giving back and enhancing the well-being of vulnerable communities and the environment, we allocate a significant share of our profits towards Social and Environmental projects. Our cofounders have direct oversight over the social and environmental initiatives of the group with the goal of Making a meaningful impact.
Our story
Founded in 1984, Bioculture Group is the pioneer in cynomolgus monkey rearing and export in Mauritius. From a family-run business, the group has expanded over the years to supply 100% Specific Pathogen Free non human primates to premier international pharmaceutical companies, universities and non-clinical research organisations.
Meet our people
Bioculture Group employs 750 people in Mauritius and another 150 through BC US LLC in the United States. For nearly 40 years, our company culture has been led by our shared values of Humility, Integrity, Compassion, Perseverance and Team Spirit focusing on the wellbeing of our staff and our animals.
What we do
For four decades, Bioculture Group has been empowering medical research through our world class expertise in the rearing and export of naturally born and 100% Specific Pathogen Free Cynomolgus monkeys with a unique genetic profile. We deploy a strong culture of care for our animals during all the steps of our operations.
Impact
Our Corporate Social Responsibility initiatives aim at empowering vulnerable populations through community development and poverty alleviation. We also focus our efforts on protecting the biodiversity in Mauritius and the neighbouring islands through education and preservation of endangered endemic wildlife.
Research News
Cynomolgus monkeys have had a crucial contribution in the development of ground-breaking treatments for illnesses and conditions ranging from diabetes to corona viruses. Equally promising strides are being made in research related to Alzheimer’s and Parkinson’s diseases lately.
